TYTianying Yang

Tianying Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tianying Yang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Aijie Xin

    Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies (SIBPT), School of Pharmacy, Fudan University, Shanghai 200032, China

    1 shared publication
  • Chunbo Li

    Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China

    1 shared publication
  • Chunbo Li

    Obstetrics and Gynecology Hospital of Fudan University

    1 shared publication
  • Fenglu Wu

    Department of Assisted Reproduction Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China

    1 shared publication
  • Guo-Wei Tu

    Department of Cardiac Intensive Care Center, Zhongshan Hospital, Fudan University, Shanghai, China

    1 shared publication
  • Jiawei Li

    Department of Kidney Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China

    1 shared publication

Latest Publications

  • Advanced Parental Age and Perinatal Risks in Twins Conceived Through In Vitro Fertilization

    by Jing Lin, Tianying Yang, Fenglu Wu, Jing Zhang, Xinggang Wang, Jiaying Lin

    Objective: To evaluate the associations between advanced parental age and perinatal risks in twins. Methods: We analyzed 7514 twin pairs conceived through in vitro fertilization. The exposure was advanced parental age (≥ 35 years), analyzed separately for mothers and fathers. Primary outcomes included birth weight discordance, small for gestational age, large for gestational age, macrosomia, low birth weight, very low birth weight, preterm birth, very preterm birth, and extremely preterm birth. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using logistic regression. Additionally, parental age was analyzed both as a categorical variable and with a restricted cubic spline. The combined effect of advanced age in both parents was further evaluated. Results: Advanced paternal age (≥ 35 years) was associated with increased odds of birth weight discordance (adjusted OR, 1.20; 95% CI, 1.01–1.42). A graded dose‐response association was evident ( p for trend = 0.026), with adjusted ORs for birth weight discordance progressively increasing across paternal age categories: 1.02 (95% CI, 0.83–1.25) for ages 30–34, 1.18 (95% CI, 0.91–1.52) for ages 35–39, and 1.41 (95% CI, 1.02–1.96) for ages ≥ 40 years, all compared to the < 30 years reference group. Restricted cubic spline analysis identified 37 years as a threshold beyond which paternal age significantly elevated birth weight discordance risk. Similarly, advanced maternal age (≥ 35 years) was significantly associated with increased small for gestational age odds (adjusted OR, 1.21; 95% CI, 1.04–1.41), with a significant trend ( p for trend = 0.012) and a restricted cubic spline–derived threshold at 30 years. When both parents were over 35, the odds of birth weight discordance (adjusted OR, 1.37; 95% CI, 1.15–1.63) and small for gestational age (adjusted OR, 1.30; 95% CI, 1.13–1.50) were significantly elevated compared to both being under 35. Conclusions: Advanced parental age was associated with elevated risks of birth weight discordance and small for gestational age in twins, suggesting it as a contributing factor to perinatal risk.

  • Open Access

    Burden of Male Infertility Among Men Aged 20–49 Years in Asia From 1990 to 2021 and Prediction to 2040: A Global Burden of Disease Study

    by Tianying Yang, Jing Lin, Xinyue Yang, Chunbo Li, Aijie Xin

    Background: This study aims to investigate the epidemiological data and trends of male infertility aged 20–49 years in Asia from 1990 to 2021. Methods: Data for this study was obtained from the Global Burden of Disease (GBD) 2021 public database. Trends in prevalence, years lived with disability (YLDs), age‐standardized prevalence rate (ASPR), and age‐standardized YLD rate (ASYR), along with their correlation with the sociodemographic index (SDI), were analyzed. A join‐point regression model was developed to assess trends across different time segments. In addition, an autoregressive integrated moving average (ARIMA) model was employed for predictions extending to 2040. Results: From 1990 to 2021, the burden of male infertility among individuals aged 20–49 years increased both globally and across all Asian regions. In East Asia, the burden was the highest in 1990 and had an initial rapid escalation through the early 1990s, then declined steadily since 1995. South and Southeast Asia experienced significantly accelerating upward trends, with South Asia saw the steepest increases. High‐income Asia Pacific and Central Asia sustained relatively low disease burdens and stable trends throughout the study period. Conclusion: The disease burden in East Asia, South Asia, and Southeast Asia remains significant, with a notable upward trend observed in South Asia and Southeast Asia. Targeted interventions and policies are needed based on the epidemiological characteristics and changing trends of different Asian regions.

  • Open Access

    NF Erythroid 2-Related Factor 2 Deficiency Enhances the Immunosuppressive Function of Monocytic Myeloid-Derived Suppressor Cells in a Peroxisome Proliferator-Activated Receptor-γ-Dependent Manner

    by Yichen Jia, Jiawei Li, Tianying Yang, Ruimin Li, Guowei Tu, Yue Qiu, Xuepeng Zhang, Ruirui Sang, Yi Shi, Shihao Xu, et al.

    Key Points: NF erythroid 2–related factor 2 (Nrf2) deficiency enhances the immunosuppressive function of monocytic myeloid-derived suppressor cells and ultimately ameliorates acute and chronic inflammatory disease in mice. The suppressive role of Nrf2−/− monocytic myeloid-derived suppressor cells could be attributed to increased levels of inducible nitric oxide synthase but decreased Arg1, the peroxisome proliferator-activated receptor- γ -dependent activation mechanism. Background: Myeloid-derived suppressor cells (MDSCs) comprise monocytic MDSCs (M-MDSCs) and granulocytic MDSCs (G-MDSCs), both of which are effective for controlling T-cell responses. Although NF erythroid 2–related factor 2 (Nrf2) participates in the expansion of MDSCs and MDSC-mediated immunosuppression, the underlying mechanisms of Nrf2 in MDSC differentiation remain poorly understood. Methods: In this study, G-MDSCs or M-MDSCs were induced and sorted from the bone marrow of wild-type (WT) or Nrf2 −/− mice using flow cytometry in vitro , with or without GW9662 treatment. Mouse models of tumorigenesis, AKI, and CKD were used to evaluate the immunosuppressive function of WT or Nrf2 −/− M-MDSCs treated with or without GW9662. Histologic analysis was performed to evaluate tumor angiogenesis or kidney injury. Immunohistochemical staining was used to evaluate lymphocyte infiltration in kidney. Masson trichrome and Sirius red staining were performed to evaluate kidney fibrosis. In addition, RNA sequencing was conducted to identify gene expression difference between WT and Nrf2 −/− M-MDSCs, with real-time PCR or western blot used to validate key findings. Results: The immunosuppressive function of M-MDSCs generated from bone marrow of Nrf2 −/− mice and sorted from Nrf2 −/− tumor-bearing mice was dramatically enhanced compared with the G-MDSC counterparts. Moreover, M-MDSCs with an Nrf2 deficiency could effectively ameliorate the inflammatory disorders in mice with AKI or CKD. Intriguingly, the efficacy of Nrf2 −/− M-MDSCs could be attributed to increased expression of inducible nitric oxide synthase but decreased levels of arginase 1, indicating an unconventional mechanism of activation. Further mechanistic studies using RNA sequencing and bioinformatics analyses identified an essential role of peroxisome proliferator-activated receptor- γ in the differentiation and suppressive ability of Nrf2 −/− M-MDSCs with which the effect could be markedly blocked with GW9662, a specific peroxisome proliferator-activated receptor- γ inhibitor. Conclusions: Our findings elucidate an immunoregulatory mechanism of Nrf2 deficiency related to M-MDSC function and provides a foundation for the application of Nrf2 −/− M-MDSCs in inflammatory diseases.


  • Open Access

    Association Between Adenomyosis and Cervical Cancer: A Retrospective Cohort Study

    by Tianying Yang, Xiaohong Chen, Keqin Hua, Chunbo Li

    The main purpose of the study was to explore the clinicopathological features and survival outcomes of patients with cervical cancer (CC) and adenomyosis and without the latter and to gain insight into the timely association between adenomyosis and CC. 991 patients with CC and adenomyosis and 3964 patients without the latter were included in this retrospective cohort study. The clinicopathological characteristics including tumor size, depth of stromal invasion, presence of lymphovascular space invasion (LVSI), infiltration into vagina or uterine body, status of surgical vaginal margin, parametrial involvement, and pelvic or para-aortic lymph nodes metastasis were compared between the CC patients with/without coexisting adenomyosis by Student's t-tests, chi-square or Fisher's exact tests. The Cox proportional hazards model was employed to evaluate potential risk factors. Survival curves were constructed using the Kaplan-Meier method. Among the cervical cancer cohort, the coexistence of adenomyosis is associated with a lower likelihood of deep stromal invasion (50.2% vs 54.6%, p < 0.0001) and vaginal infiltration (25.8% vs 29.1%, p = 0.041) compared with CC patients without adenomyosis. There were no significant differences in tumor size, presence of LVSI, uterine body infiltration, status of surgical vaginal margin, parametrial involvement, and pelvic or para-aortic lymph nodes metastasis between both groups. However, adenomyosis did not remain as an independent prognostic factor for CC (HR 0.938, 95% CI: [0.72-1.22], p = 0.636) and did not reach statistical significance in the survival analysis (log rank test, p = 0.587). CC patients with coexistent adenomyosis were associated with less aggressive tumor behavior including deep stromal invasion and vaginal infiltration. However, adenomyosis was not a prognostic factor for CC survival.